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ABBREVATIONS 
 
DM   –  Diabetes mellitus 
HTN –  Hypertension 
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PTA – Percutaneous Transluminal Angioplasty 
TASC – TransAtlantic InterSoceity Consensus 
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INTRODUCTION 
 
According to the 2007 Inter-Society Consensus for the Management of Peripheral 
Arterial Disease (TASC II), acute limb ischemia is defined as a sudden decrease in limb 
perfusion that causes a potential threat to limb viability (manifested by ischemic rest pain, 
ischemic ulcers, and/or gangrene) in patients who present within two weeks of the acute 
event1. 
The management of acute arterial occlusion remains a challenge for vascular specialists. 
Surgical thromboembolectomy and bypass grafting were the mainstays of therapy for 
many years2. Subsequently, thrombolytic therapy and percutaneous transluminal 
angioplasty (PTA) have become treatment options for selected patients. 
Despite these advances, the morbidity, mortality, and limb loss rates from acute lower 
extremity ischemia remain high. Thus, regardless of the treatment modality used, early 
diagnosis and rapid initiation of therapy are essential in order to salvage the ischemic 
extremity. 
The best defense against limb loss is prompt initiation of therapy. Thus, once the 
diagnosis of acute arterial occlusion has been made by history and physical examination, 
the Seventh ACCP Consensus Conference on Antithrombotic Therapy recommends that 
the patient should immediately receive 10,000 units of intravenous heparin followed by a 
continuous heparin infusion3. Anticoagulation will prevent further propagation of 
thrombus, and inhibit thrombosis distally in the arterial and venous systems due to low 
flow and stasis. Time is crucial, the decision to administer heparin is based upon the 
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clinical evaluation and should not be delayed while waiting for diagnostic procedures to 
be performed. 
Following the initiation of heparin, treatment then varies depending upon the viability of 
the limb. Options include surgery and thrombolytic therapy 
Patients found to have an ischemic but viable extremity on clinical examination should 
undergo urgent arteriography in order to plan surgical or medical revascularization. There 
are several findings on arteriography which are used to determine if thrombolytic 
therapy, PTA, or surgical revascularization is the most appropriate treatment. These 
include: 
 
  •  The presumed etiology (embolus versus thrombus) 
  •  The location and length of the lesion 
  •  The duration of symptoms 
  •  The availability of autologous vein for bypass grafting 
  •  The suitability of the patient for surgery 
 
Patients with a threatened extremity should undergo emergent surgical revascularization. 
The majority of these patients have had an embolic event, and irreversible changes can 
occur within as little as four to six hours of profound ischemia. While pharmacologic 
thrombolysis may successfully dissolve the embolus, the time required is usually too long 
to allow this to be an acceptable alternative to surgery. 
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Patients with nonviable extremities should undergo prompt amputation. Arteriography is 
usually not necessary, since the level of amputation is determined by clinical findings and 
by the viability of tissues at the time of surgery. Every effort should be made to preserve 
as many joints as possible, in order to decrease the work of ambulating with a prosthesis 
and to improve the chances for successful rehabilitation. Delays in amputation of a 
nonviable extremity can result in infection, myoglobinuria, acute renal failure, and 
hyperkalemia and eventually death. 
 
Extraction of emboli or thrombi by the use of an inflatable balloon catheter is considered 
as relatively a simple operation. However, perioperative mortality remains high and can 
be attributed to serious underlying cardiac disease or to the consequences of the 
reperfusion of the ischemic limb causing release of toxic metabolites. 
Most studies report a 30 day mortality exceeding 20% and amputation rates above 10% 
following arterial embolectomy4,5,6.  
 
 This study is to evaluate the perioperative outcome in patients presenting with first 
episode of acute arterial occlusion of lower extremity. 
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ACUTE LIMB ISCHEMIA 
PATHOPHYSIOLOGY 
Acute limb ischemia may occur as the result of embolization or in-situ thrombosis 
(Table.1). Emboli originate from the heart in more than 90% of cases7 and normally 
lodge at the site of an arterial bifurcation such as the distal common femoral or popliteal 
arteries. The decreasing prevalence of rheumatic heart disease underlies a diminishing 
proportion of embolic versus thrombotic causes for acute limb ischemia. When 
embolization occurs, it usually does so in the setting of atrial fibrillation or acute 
myocardial infarction, when portions of atrial or ventricular mural thrombus detach and 
embolize to the arterial tree. 
 
Table.1 Classification of Acute Limb Ischemia 
Bypass graft occlusion 
Prosthetic conduit  
Intimal hyperplasia at the anastomoses(usually distal) 
Occlusion without a demonstrable lesion 
Autogenous conduit (e.g., saphenous vein graft) 
Retained valve cusp of an in-situ graft 
Stenosis at the site of a prior venous injury(e.g., superficial phlebitis) 
Native arterial occlusion 
Thrombosis at the site of an atherosclerotic stenotic lesion 
Embolism to an arterial bifurcation 
Thrombosis within a near-normal artery, usually as the result of a hypercoagulable state 
Arterial inflammatory diseases such as giant cell arteritis (Takayasu’s aortitis) 
Thrombosis of an aneurysm (e.g., popliteal aneurysm) 
Rare etiologies (e.g., popliteal entrapment syndrome, adventitial cystic disease of the 
popliteal artery) 
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It is often difficult to distinguish embolus from thrombosis, but embolic occlusions 
should be suspected in patients with the following features:  
 
• acute onset where the patient is often able to accurately time the moment of the 
event 
• prior history of embolism 
• known embolic source, such as cardiac arrhythmias 
• no prior history of intermittent claudication 
• normal pulse and Doppler examination in the unaffected limb.  
Thrombosis as an etiology for acute limb ischemia is a much more diverse category than 
embolization. With the increased use of peripheral arterial bypass grafts for chronic limb 
ischemia, and noting the finite patency rate of any bypass graft conduit, it is not 
surprising that acute graft occlusion is now the most frequent cause of acute lower 
extremity ischemia in most centers. 
Symptoms may be less dramatic than embolic occlusion, depending on the extent of 
collateral flow across the site of occlusion. In addition to the presence of collateral 
channels, the location of the occlusion may also play a critical role in the severity of limb 
ischemia. For example, occlusion of the popliteal artery results in profound limb 
ischemia, since it is the only artery crossing at the level of the knee. By contrast, 
occlusion of the anterior tibial artery is often asymptomatic because the posterior tibial 
and peroneal arteries can function as alternate parallel channels to supply the foot. 
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Irrespective of the etiology of ischemia, the end result is the build-up of toxic byproducts 
within the ischemic tissue bed. These toxins include the free radicals, which are oxygen-
derived, chemically reactive molecules that are responsible for the injury that occurs after 
ischemia and reperfusion. Ischemia induces leakage of protein and fluid from the 
capillary bed, resulting in tissue edema8.  
Hydrodynamic pressure in the extravascular space rises to a level that competes with 
venous outflow, perpetuating a vicious cycle that can eventually impede arterial inflow. 
At first, this process occurs at a microscopic level, but it may progress to the 
development of high tissue pressures at a regional level and the clinical entity known as 
the compartment syndrome. The development of a compartment syndrome is hastened by 
the abrupt reperfusion of a previously ischemic tissue bed, a phenomenon that explains 
the relatively frequent need for fasciotomy after lower extremity surgical 
revascularization for severe limb ischemia9.  
 
DIAGNOSIS 
Acute limb ischemia is a clinical diagnosis. Patients complain of numbness and pain in 
the extremity, progressing in severe cases to motor loss and muscle rigidity. Examination 
reveals the absence of palpable pulses, and the location of the pulse deficit allows one to 
predict the site of arterial occlusion.  
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The “5 Ps” have been used as a mnemonic to remember the presentation of a patient with 
acute limb ischemia. 
Paresthesia 
Pain 
Pallor  
Pulselessness 
Paralysis 
In some cases, a sixth P is added—Poikilothermia, meaning equilibration of the 
temperature of the limb to that of the ambient environment (coolness). The process is 
sometimes confused with deep venous thrombosis by an inexperienced observer.  
Although a deep venous thrombosis may manifest as limb ischemia when severe 
(phlegmasia cerulea dolens), profound lower extremity edema is uncommon in pure 
arterial ischemia. Occasionally, a patient with arterial ischemia and pain at rest keeps the 
extremity in a dependent position and edema may develop; such a scenario may be 
apparent if an adequate history is obtained. Pain may either be constant or elicited by 
passive movement of the involved extremity.  
History should include a description of the duration, location, intensity, and suddenness 
of the onset of pain and change over time. Embolic occlusions are usually quite sudden 
and of great intensity, such that patients often present within a few hours of onset. The  
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past history should state whether or not the patient has a history of intermittent 
claudication, previous leg bypass or other vascular procedures, and history suggestive of 
embolic sources such as cardiac arrhythmias and aortic aneurysms.  
General atherosclerotic risk factors (smoking, hypertension, diabetes, hyperlipidemia, 
family history of cardiac or vascular events) should be recorded because these can be 
predictors of periprocedural mortality. 
In an effort to classify the extent of acute ischemia for standardization reporting of 
outcome, the Society for Vascular Surgery/International Society for Cardiovascular 
Surgery (SVS/ISCVS) (now SVS) ad hoc committee was established and published what 
has now come to be known as the Rutherford criteria, after Dr. Robert Rutherford10. 
The following three classes were defined:  
• Class 1: the limb is viable and remains so even without therapeutic 
intervention.  
 
 
• Class 2: the limbs are threatened and require revascularization for salvage.  
 
 
• Class 3: those limbs that are irreversibly ischemic and infarction has 
developed such that salvage is not possible.  
The initial work of the reporting standards committee was revised several years later11, 
dividing the middle category into two subclassifications: 
• Class 2A for limbs that are not immediately threatened 
• Class 2B for those limbs that are severely threatened to the point where urgent 
revascularization is necessary for salvage. 
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The anatomic level of the arterial stenoses can be predicted from palpation of pulses in 
the femoral, popliteal, and ankle regions. Even the most astute clinician sometimes has 
difficulty in discerning his or her own digital pulse from the patient’s pedal pulse.  
Hence, the use of a Doppler instrument is advantageous to document the flow status in 
the both the pedal arteries and also the venous flow at the ankle level to provide an 
objective and quantitative assessment of the extent of arterial insufficiency12. The 
severity of ischemia classification to that of the Doppler flow signals by Dr. Rutherford is 
shown in the table below. 
Category  
 
Description/prognosis  
 
Findings  
 
Doppler 
signals†  
 
  Sensory loss Muscle weakness Arterial Venous 
I. Viable Not immediately threatened None None + + 
 
II. Threatened 
a. Marginal Salvageable if promptly treated Minimal (toes) or none None (Often) - + 
b. 
Immediate 
Salvageable with immediate 
revascularization 
More than toes, associated 
with rest pain Mild, moderate 
(Usuall
y) - + 
 
III. 
Irreversible 
Major tissue loss or permanent nerve 
damage inevitable Profound, anesthetic 
Profound, paralysis 
(rigor) - - 
† Obtaining an ankle pressure is very important. However, in severe ALI, blood flow velocity in the affected arteries may be so low that 
Doppler signals are absent.  
Differentiating between arterial and venous flow signals is vital: arterial flow signals will have a rhythmic sound (synchronous with cardiac 
rhythm) whereas venous signals are more constant and may be affected by respiratory movements or be augmented by distal compression 
(caution needs to be taken not to compress the vessels with the transducer).Reproduced from Rutherford RB et al. J Vasc Surg 
1997;26(3):517–538. 
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In some centers, transcutaneous oxygen tension has also been used to assess the severity 
of peripheral arterial occlusion13 as well as to predict the most appropriate level of 
amputation. 
Duplex ultrasound is a non invasive test to define the anatomic extent of peripheral 
arterial disease14. Although duplex has been useful in documenting the patency of a 
single arterial segment such as a stented superficial femoral artery or a bypass graft, 
evaluation of the entire lower extremity arterial tree remains imprecise, and its adequacy 
as the sole diagnostic modality for planning a percutaneous or open surgical intervention 
remains controversial. 
Contrast arteriography remains the gold standard with which all other tests must be 
compared. 
Magnetic resonance (MR) angiography is being used with greater frequency in patients 
with peripheral arterial disease15. Using gadolinium as an MR contrast agent, the 
specificity and sensitivity of the test exceed that of duplex ultrasonography and approach 
the accuracy of standard arteriography. It has got the advantage in demonstrating patent 
tibial arteries undetected with less sensitive conventional arteriography, identifying 
potential target vessels for an otherwise unfeasible lower extremity reconstructive bypass 
procedure. Today, MRA is widely employed in patients with chronic renal insufficiency 
to limit the dye load.  
Another noninvasive imaging modality, computed tomographic (CT) angiography, is 
gaining appeal as a means of delineating anatomy to provide a means of localizing the 
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extent and severity of occlusive disease16. With future improvements in hardware and 
software technology, it is likely that MR and CT angiography will effectively replace 
conventional diagnostic arteriography, and arterial cannulation will be reserved solely for 
percutaneous interventional therapies. 
TREATMENT 
Acute lower extremity peripheral arterial occlusion may culminate in major amputation if 
revascularization is not undertaken in a prompt and efficient manner. There exist two 
standard treatment modalities for improving lower extremity arterial perfusion: operation 
and thrombolysis. Once the diagnosis is made, adequate systemic anticoagulation is 
instituted. A bolus of unfractionated heparin is standard, followed by a continuous 
infusion to maintain the activated partial thromboplastin time (aPTT) in a therapeutic 
range. The goal of anticoagulation is twofold: (1) to decrease the risk of thrombus 
propagation and (2) in the case of presumed embolic occlusion, to prevent recurrent 
embolization. 
Routine blood studies and coagulation tests should be drawn before heparin is 
administered. A plain chest radiograph and electrocardiogram should be obtained in 
every patient. In patients with suspected embolism, an echocardiogram should be 
obtained as soon as time allows 
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There exist several basic therapeutic options to pursue in patients with acute limb 
ischemia: 
1. The first option is anticoagulation alone. If the ischemia is nonthreatening (e.g., 
Rutherford class 1 or 2A), such a nonaggressive course may be appropriate. 
Angiographic evaluation and elective revascularization may then be undertaken 
after the patient has been fully prepared and other co-morbidities such as 
concurrent coronary artery disease have been addressed.  
2. Patients who present with more severe ischemia (Rutherford class 2B) require 
some form of intervention to prevent progression to irreversible ischemia and 
limb loss. These patients should undergo early angiographic evaluation with 
adequate imaging of the affected and the unaffected extremity. Arterial access is 
accomplished at a site distant from the ischemic extremity using a contralateral 
femoral artery or brachial approach to avoid the creation of needle entry sites in 
an artery that might subsequently be infused with a thrombolytic agent. 
Early angiographic imaging should be undertaken in all patients, with the sole exception 
of those patients with common femoral emboli. These individuals can be taken directly to 
the operating room for embolectomy, but intraoperative completion angiography is 
necessary to rule out retained thromboembolic material17.  
Once adequate diagnostic information has been obtained from the angiogram, the 
clinician is in a position to make a decision on whether to pursue a percutaneous or open 
surgical option. 
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• Thrombolytic therapy: Thrombolytic therapy with the plasminogen 
activators (urokinase, alteplase, or reteplase) has been demonstrated to 
lower the morbidity and mortality when compared with a traditional 
approach of immediate operative revascularization18,19. These benefits 
appear to be especially prominent in patients with medical co-morbidities 
when early revascularization is necessary. The complication rate is high 
when such patients are taken urgently to open surgical revascularization 
without the ability to adequately prepare the patient for operation.  
• Mechanical thrombectomy: Removal of intra-arterial thrombus with a 
mechanical device has gained popularity over the last several year20,21. 
Some devices rely on hydrodynamic, rheolytic forces to extract the 
thrombus, whereas others use rotating components to fragment the clot. 
Mechanical thrombectomy devices can be used in conjunction with 
pharmacologic thrombolysis.  
• Immediate open surgical revascularization: Early operation has been 
remarkably effective in restoring adequate blood flow to an ischemic 
extremity. The relatively simple procedure of balloon catheter 
thromboembolectomy, however, has fallen into disfavor for all but 
embolic occlusions. The underlying lesion responsible for the thrombotic 
event must be identified and corrected to avoid early reocclusion. For this 
reason, long atherosclerotic occlusions are best treated with the placement 
of a bypass graft22. 
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Unfortunately, immediate open surgical interventions have been associated with an 
unexpectedly high risk of major morbidity and mortality.  
Blaisdell and associates first reported this finding, noting a 30% perioperative mortality 
rate in a review of more than 3000 patients in the published works from the 1960s and 
1970s23. Although the results have improved since the publication of Blaisdell’s 
landmark review, mortality rates continue to remain undesirably high. This observation 
appears to relate to the relatively common occurrence of cardiopulmonary complications 
developing in these medically compromised patients, patients who are ill prepared to 
undergo early operative intervention18.  
The severity of ischemia precludes adequate preoperative preparation of the patient, and 
complications such as perioperative myocardial infarction, cardiac arrhythmia, or 
pneumonia appear to underlie the unacceptable mortality rate in these patients. 
Additionally, wound complications and delayed healing are common in these patients. 
Hence, despite successful limb salvage, patient dissatisfaction is frequent.  
The mortality rate from open surgical treatment of acute limb ischemia has been 
reconfirmed in numerous studies published after Blaisdell’s landmark series. 
Dale reviewed cases of nontraumatic extremity ischemia and observed an 11% mortality 
rate in those with embolism, versus 3% in those with acute thromboses24. Several years 
later, Jivegård and colleagues documented a mortality rate of 20% in patients presenting 
with acute arterial embolism or thrombosis, a finding that was explained by preexisting 
cardiac disease in these patients25. 
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Pharmacologic Thrombolytic Therapy 
Noting the high morbidity from primary open surgical revascularization in patients 
suffering from true limb-threatening lower limb ischemia, three randomized, prospective 
clinical trials were organized to compare thrombolytic therapy and immediate open 
surgical revascularization.  
The first study, the Rochester series, compared urokinase to primary operation in a 
single-center experience of 114 patients presenting with what has subsequently been 
called hyperacute ischemia18. Patients enrolled in this trial all had severely threatened 
limbs (Rutherford class 2b) with mean symptom duration of approximately 2 days. After 
1 year of follow-up, 84% of patients randomized to urokinase were alive compared with 
only 58% of patients randomized to primary operation  By contrast, the rate of limb 
salvage was identical at 80% in the two groups.  
The second prospective, randomized analysis of thrombolysis versus surgery was the 
Surgery or Thrombolysis for the Ischemic Lower Extremity (STILE) trial19. At its 
termination, 393 patients were randomized to one of three treatment groups: rt-PA, 
urokinase, or primary operation. Subsequently, the two thrombolytic groups were 
combined for purposes of data analysis when the outcome was found to be similar. 
Thrombolysis appeared more effective in patients with graft occlusions. The rate of major 
amputation was higher in native arterial occlusions treated with thrombolysis (10% 
thrombolysis vs. 0% surgery at 1 year). By contrast, amputation was lower in patients 
with acute graft occlusions treated with thrombolysis. These data suggest that 
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thrombolysis may be of greatest benefit in patients with acute bypass graft occlusions of 
less than 14 days.  
The third and final randomized comparison of thrombolysis and surgery was the 
Thrombolysis or Peripheral Arterial Surgery (TOPAS) trial26, funded by Abbott 
Laboratories. 544 patients were randomized to a recombinant form of urokinase or 
primary operative intervention. After a mean follow-up period of 1 year, the rate of 
amputation-free survival was similar in the two treatment groups: 68% and 69% in the 
urokinase and surgical patients, respectively 
Percutaneous Mechanical Thrombectomy Devices 
Numerous percutaneous mechanical thrombectomy (PMT) devices are currently available 
in the United States for dialysis graft declotting; however, only two devices are approved 
for infrainguinal arterial use in the United States. The devices may be classified into 
“aspiration” or “microfragmentation-only” devices. The latter embolize the 
microfragments that are created by the mechanical component of the device.  
Many of these devices were designed primarily for dialysis graft declotting, where 
embolization is not seen as a device limitation. However, when used for peripheral 
arterial occlusion, the risk of downstream embolization is clinically significant.  
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REVIEW OF LITERATURE 
 
In 1854, Virchow was the first to use the term embolus in the description of sudden 
obstruction of an artery by material that originated from a distal site. The term is derived 
from “embolos,” a Greek term meaning plug. The occlusive material may consist of 
platelet-fibrin thrombus, cholesterol debris, laminated aneurysmal thrombus, or a foreign 
body that has gained access to the vascular system. 
Originally, the treatment of an arterial embolus was solely observational, which 
eventually terminated in limb loss or death. In 1911, the first successful arterial 
embolectomy was performed on the femoral artery by Labey27. 
In the early 1900s, the initial successful reports of surgical removal of embolic material 
were described and operative management slowly gained acceptance24.  
Non operative methods included intermittent positive and negative pressure28, 
intermittent venous occlusion29 and the oscillating bed. Surgical extraction lagged well 
behind these conservative treatment modes30. 
Various methods of performing embolectomy were tried, including direct arteriotomy, 
retrograde flushing of the arterial tree31,32, the use corkscrew wire devised by Shaw33, and 
various suction devices34. 
One of the great advances in treatment of patients with thromboembolism given by 
Murray35 in 1933, the introduction of heparin for use before, during, and after surgical 
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intervention. Intravenous heparin infusions decreased the propagation of thrombus, 
stabilized the clot, and recruited collateral vessels. 
Early in its evolution, the complete removal of thromboembolic material, especially when 
associated with large amounts of propagated thrombus, remained problematic. A variety 
of methods, including suction catheters, vigorous arterial flushing, and external 
compression on the limbs, were used with moderate success. 
In 1963, Fogarty36 and associates proposed the use of a balloon catheter that offered a 
significant advance for the retrieval of thrombus, distal and proximal to the embolic site.  
Lavenson37 and co workers and Yao38 and co workers suggested that measurements of 
distal arterial pressure in the extremities may offer valuable information in assessing limb 
viability. They suggested that distal pressures below 30 mm Hg often are associated with 
eventual limb loss. 
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AIM 
 
 
To evaluate the perioperative outcome of all patients presented with first episode of acute 
arterial occlusion of lower limbs to our department for the period of two years. 
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MATERIALS AND METHODS 
 
Design of the study: Prospective 
 
Study period: February 2007 to February 2009 
 
All patients presented with acute lower limb ischemia to the Department of vascular 
surgery, Madras Medical College, Chennai over the above period were studied. The 
patients presented for the first episode alone were included in the study. Vascular 
examination was done thoroughly in all patients.  
 
They were classified according to the Rutherford’s classification of acute limb ischemia, 
duration of ischemia, level of occlusion, associated risk factors, probable etiological 
factor and treatment offered.  
 
All patients were investigated preoperatively by echocardiography and looked for the 
source of embolism. In selected group of patients, preoperative angiograms were done 
depends on the severity of ischemia. Those patients presented with limb threatening 
ischemia were taken up directly to the operation theatre after minimum basic 
investigations. 
 
The patients included in the study were divided according to the etiology of embolism or 
thrombosis. The diagnosis of embolism or thrombosis was determined from a 
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consideration of history, clinical examination, presence or absence of clot in 
echocardiography and angiography. 
 
All patients who had undergone surgeries alone were taken up for the study. The patients 
being managed conservatively with oral anticoagulation or thrombolytic agents were 
excluded from the study. Only those who underwent surgeries alone were analysed for 
category improvement, outcome including the mortality during the in hospital 
postoperative period. 
 
Inclusion criteria 
First episode of Acute Lower extremity Ischemia     
Acute Thrombosis 
Acute Embolism 
Exclusion criteria 
Multiple thromboembolism involving other regions 
Recurrent thrombosis 
Bypass Graft Thrombosis 
Dissection 
Trauma  
DVT gangrene 
Septic arterial occlusion 
 
 24
Depending on the limb viability status and irrespective of the duration of ischemia, all 
patients were undergone revascularization procedures in emergencies as well as in 
elective theatres. All limb threatening ischemia patients underwent emergency 
embolectomy or thrombectomy and patients with non limb threatening ischemia were 
angiographically evaluated and subjected for elective bypass procedures. Compartmental 
fasciotomy were done as and when required during the postoperative period. All patients 
presented with irreversible ischemia underwent amputations were also included in the 
study. Patients who had successful outcome following revascularisation in the 
postoperative period were made ambulant independently and following amputations with 
walking frame.  
 
Secondary major amputations and minor amputations were performed for patients those 
advanced ischemia and depending on the line of gangrene demarcation respectively, 
following revascularization. 
 
All patients were started on therapeutic heparinisation soon after admission. This was 
continued postoperatively.This was slowly overlapped with oral anticoagulation only 
when the revascularised limb do not require any further surgical intervention before the 
time of discharge. 
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STATISTICAL ANALYSIS 
 
 
This study was statistically analysed by the Chi-square test to compare the duration, 
level, etiology and severity of ischemia to the outcome and mortality. 
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OBSERVATION AND RESULTS 
 
A total number of 60 patients were admitted to the department of vascular surgery with 
acute lower limb ischemia over the two year period. Out of this, 41 patients required 
surgeries and were prospectively analysed. Rest of  the others were not included in the 
study. They were predominantly of males(Male : Female ratio, 34 : 7).  
 
The age of presentation was ranged from 23 to 70 years and a mean of 42.3 years.  
 
The duration of ischemia from the time of onset of symptom to admission was ranged 
from 12 hours to a maximum of 25 days, mean of 6.7 days. 
 
Symptoms 
In our study, only five patients had previous history of claudication, out of which only 
one patient was having embolic etiology which was neglected for 20 days. He presented 
with incapacitating claudication. 
 
Majority of the patients had presented with more than 4 p’s. 
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Affected side 
 
In our study, 18 patients presented with right lower limb involvement, 13 patients with 
left lower limb and 10 patients with bilateral lower limb involvement. 
        
                                         
RIGHT
LEFT
BILATERAL
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Anatomical  level 
 
Out of 41 patients, majority(14 patients)of them had iliac artery occlusion, nine had 
popliteal artery and eight had femoropopliteal artery occlusion. 
Out of the 10 bilateral limb involvement, seven had aortoiliac occlusion and three 
patients had different level of occlusion in two different limbs, and seven were in the 
embolism group. In aortoiliac occlusion, five out of seven had saddle embolism(71%) 
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Ankle Brachial Index(ABI) 
 
In the study, 35 patients detected to have no flow in the hand held Doppler at the time of 
presentation, four had decreased ABI and one had venous flow. 
 
Class Pre op ABI 
 No flow Decrease Venous 
I 5 2 0 
IIa 3 1 0 
IIb 9 1 1 
III 16 0 0 
Both 3 0 0 
Total 36 4 1 
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Risk factors 
 
Out of 41 patients, only 19 patients were associated with comorbid illness.  
Most of the patients(10 patients, 24%) had previous history of rheumatic heart 
disease(RHD) with severe mitral stenosis(MS). Transthoracic echocardiography(TTE) 
could pick up cardiac source of embolism in only four of these patients(out of 10).The 
rest of them were not subjected for transesophageal echocardiography(TEE) for want of 
availability. Four patients associated with coronary artery disease(CAD), diabetes 
mellitus(DM) and hypertension(HTN), two patients had CAD alone, two had HTN and 
cerebrovascular accident(CVA) and one had history of diarrhea. 
Out of the 41 patients, four patients had atrial fibrillation of which three were associated 
with RHD and MS and one with CAD alone who also had ascending aortic aneurysm. 
 
Risk Factors 
 
n 
 
Embolism 
 
Thrombosis 
 
Clot in the 
cardiac chamber 
RHD, severe MS 10 10 0 4 
CAD, DM, HTN 4 3 1 2 
CAD alone 2 2 0 0 
HTN, CVA 2 0 2 0 
Diarrhoea 1 0 1 0 
 
 
Majority of the patients (n = 32, 78%) were smokers, all of them were male patients. 
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Rutherford’s classification of acute limb ischemia 
 
According to the Rutherford’s classification, 16 patients were presented with class III 
ischemia, 11 patients with class IIb, four patients with class IIa and seven with class I, 
and three other patients with both classes of IIa and IIb in two different limbs. 
 
Rutherford’s Class Number of patients(%, percentage) 
I 7(17%) 
IIa 4(9%) 
IIb 11(26%) 
III 16(39%) 
IIa & IIb 3(7%) 
 Total                    41 
 
Echocardiography 
In our the study, six showed intracardiac clot as the source of embolism, out of which 
four were associated with RHD and two with CAD and one also with ascending aortic 
aneurysm. 
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   Class IIb, Limb threatening Ischemia 
 
  
Class III Ischemia, after surgical attemption – subsequently Secondary amputation 
 
 
 
Class III, Irreversible ischemia 
     
 
Left foot drop  
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Probable Etiology 
 
Most of our patients(n = 29, 70%) had embolism and other 30%(12 patients) were having 
thrombosis due to arteriosclerosis in 9 patients, thromboangiitis obliterans in two and 
hypercoagulable in one patients. 
 
 
 
 
 
 
 
 
 
Angiography 
 
Seven patients were subjected for computed tomography angiogram, out of which four 
had thrombosis and three had embolism. Two other patients underwent conventional 
angiography and intraoperative angiography. Out of these patients, four were in class I, 
three were in class IIa and two were in class III ischemias. 
Out of these four thrombosis, three underwent bypass procedures and one underwent 
primary amputation. Out of three embolism group patients, two underwent bypass and 
one underwent embolectomy. 
70%
30%
Embolism
Thrombosis
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Surgeries performed 
 
Most of the surgeries were carried out as an emergency procedures. 
Unilateral femoral artery embolectomy in 13 patients(12 were done in emergency and 
one in elective for class I ischemia), out of which four patients were in class III ischemia. 
Unilateral femoral artery thrombectomy, both femoral and popliteal thrombectomy and 
embolectomy in each of three patients. 
 
Out of the 10 bilateral limb involvement, seven of them underwent emergency femoral 
embolectomy, others underwent femoral thrombectomy, aortoiliac artery bypass and 
primary above knee amputation in one limb with other limb salvaged with forefoot 
amputation done for class III ischemia in each of the three patients. 
 
Unilateral popliteal artery embolectomy were done in four patients and thrombectomy in 
two patients. 
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45 year old male Juxta renal aortic thrombotic occlusion presented with class I 
ischemia of left lower limb. 
This patient is known claudicant with right iliac artery occlusion on conservative 
management 
 
CT Angiogram showing right iliac artery occlusion 
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SURGICAL PROCEDURE  
 
 
Infrarenal aortic thrombectomy 
   
 
     Aorta declamped 
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Aorto Bi Iliac artery 14/7 mm PTFE bifurcated Bypass grafting 
 
     Proximal anastomosis 
                            
     Distal anastomosis 
    
 
Postoperatively, patient was ambulant normally, with ABI -1.0 in both 
lower limbs 
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Unilateral fem embolectomy bilat fem embolectomy primary amputation bypass 
uni pop embolectomy uni pop thrombectomy fem & pop thrombectomy bilat fem thrombectomy
 
 
Bypass procedures were performed in five patients, out of which aorto biliac in one 
patient for class I ischemia due to aortoiliac artery thrombosis, aortounifemoral artery 
bypass grafting done in one patient for left iliac artery thrombosis presented as class IIa 
and infrainguinal bypasses done in three patients(CFA to mid SFA -1, CFA to PTA – 1, 
proximal to distal popliteal artery – 1) for class I ischemia. Two of them were due to 
embolism. 
Primary amputations were done in six patients, five for unilateral limb ischemia(above 
knee in four and below knee in one patients) and in one patient for bilateral limb ischemia 
where right above knee amputation was done. 
Majority of the patients underwent leg fasciotomy following embolectomy or 
thrombectomy. 
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70 year  old male presented after 15 days with class I ischemia of left LL  
Echocardiography showed Ascending Aortic Aneurysm 
On CT angiographic evaluation showed left external iliac artery was tortous , SFA 
loaded with thrombus and distal reformation of posterior tibial artery  
Right LL tibial arterial occlusive disease 
 
          
 
Common femoral artery to posterior tibial artery reversed sapheous vein bypass 
      
Proximal      Distal 
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45 year old male known c/o RHD, Severe MS for 20 years 
Stopped anticoagulation and also not willing for surgery 
 
He presented with class III ischemia due to femoral artery embolism  
Embolectomy + fasciotomy was done 
 
  
Patient with foot drop splint and ambulant with walking frame 
 
 
Unfortunately, patient developed groin wound infection with femoral artey blow out 
which was ligated. Subsequently he required an Above knee amputation and 
expired. 
Cause of death: Multifactorial (Cardiac, Sepsis and 3 times emergency surgery) 
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45 year old male with bilateral LL ischemia, Right IIb and Left IIA 
 
Bilateral femoral artery embolectomy done, Distal pulses reappeared 
 
 
 
Both leg fasciotomy, anterior compartment muscles non viable, debrided 
            
 
Postoperatively patient developed hematuria, respiratory distress – later 
EXPIRED 
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Relationship of level of occlusion to the outcome in acute lower limb ischemia  
 
Level Outcome 
 Limb 
Salvaged 
Amputation Expired Total 
Normal With disability    
Aortoiliac 1 1 2 3 7 
Iliac 7 3 3 1 14 
Fempop 4 0 1 3 8 
Popliteal 4 2 3 0 9 
Both 0 2 0 1 3 
Total  16 8 9 8 41 
 
P = 0.18002, not significant 
 
In our study, both iliac(41.7%) and popliteal(25%) arterial level of occlusion had 
favourable outcome compared to other levels of occlusion  for limb salvage. 
At the same time the rate of amputation was higher in both these levels(33.3% each). The 
reason for the higher rate was all of them were in class III ischemia. This difference is not 
statistically significant. 
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Duration of ischemia to the mortality 
 
            Days Mortality 
 Yes No Total 
< one week 8 21 29(70.7%) 
>one week 0 12 12(29.3%) 
 
P < 0.05, significant 
 
We observed that, majority(70.7%) of the patients presented within a week duration of 
ischemic symptoms.  And also all the patients died were in the less a week group. Out of 
which 75% were in embolism group and in class III ischemia. The reason of this higher 
mortality could be due to the associated cardiac morbidity as well as the severity of 
ischemia. 
 
 At the same time, all of them presented after one week underwent surgery were survived. 
In this majority were in embolism group(8 out of 12  patients). This was statistically 
significant. 
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Comparison of side of ischemia to the mortality 
 
Side Mortality 
Yes No Total 
Right 4 14 18 
Left 0 13 13 
Bilateral 4 6 10 
 
P = 0.5212, not significant 
The side does not have any influence in the outcome. Although, there is 40% mortality in 
the bilateral limb ischemia patients. This difference is not statistically significant. 
Relationship of preoperative ABI with outcome 
 
 
 Preop ABI 
  
Outcome 
Limb salvaged  
Normal With disability Amputation Expired Total 
No flow 12 7 9 8 36 
Decreased 3 1 0 0 4 
Venous 1 0 0 0 1 
P = 0.51891, not significant 
The above table compares the outcome of patients with preoperative Doppler audio 
signals in acute lower limb ischemia. There is no significant difference noted in these 
groups. 
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Comparison of the level of ischemia with the mortality 
 
Level  Mortality  
 Yes No  
Aortoilac 3 4 7 
Iliac 1 13 14 
Fempop 3 5 8 
Pop 0 9 9 
Both 1 2 3 
 
P = 0.09202, not significant 
 
Iliac and popliteal arterial level of occlusions were having better survival rate(> 90%) 
when compared to that of aortoiliac and femoropopliteal arterial occlusions. Although the 
level of occlusion was not statistically significant to that of the mortality, we found that 
42% of the saddle aortoiliac occlusions were died. Conversely, 37% of mortality rate was 
found in lower level occlusions also e.g. femoropopliteal level. 
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Relationship of etiology and mortality 
Etiology Mortality 
 Yes No Total 
Embolism 6 23 29 
Thrombosis 2 10 12 
 
P = 0.76742, not significant 
 
Although the mortality in our study was higher in the embolism group compared to that 
of thrombosis group, the difference is not statistically significant. Because fewer number 
of cases in thrombosis group and the mortality in this group reflects the sequelae of 
cardiac disease. 
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Relationship of etiology with the outcome 
Etiology Outcome 
 Limb salvaged Major Amputation Expired Total 
Embolism 17 6 6 29 
Thrombosis 7 3 2 12 
Total 24 9 8 41 
 
P = 0.93129, not significant  
In our study, the overall limb salvage rate and major amputation rate both primary and 
secondary were 58.5% and 22%, respectively.   
 
When etiology was related to that of limb salvage, the limb survival for both embolism 
and thrombosis were 58.6% and 58.3%, respectively. There is not much of any 
differencein both the groups. And the major amputation was also nearly equal for both 
the groups(Embolism - 20.7%, Thrombosis - 25%). Our thrombosis group were relatively 
small in numbers. We considered the etiology of thrombosis in our patients who had prior 
history of claudication and or had lower limb muscle wasting. In few cases, angiography 
were sufficient to permit the accurate diagnosis of thrombosis.  
 
The mortality was higher in the embolism group(20.6%) compared to the thrombosis 
where the mortality rate was 16.6%. This difference was not statistically significant  
(P = 0.93129). 
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Limb salvagibility to the class of ischemia 
 
Class Outcome 
 Limb salvaged Major 
amputation 
Expired Total 
I 7 0 0 7 
IIa 4 0 0 4 
IIb 11 0 0 11 
III 1 9 6 16 
Both 1 0 2 3 
Total 24 9 8 41 
P < 0.001, Highly significant 
The outcome of patients according to the Rutherford class were analysed, we found that 
all patients presented with class I, IIa and IIb were having 100% limb salvagibility, 
whereas only one patient of class III ischemia limb was salvaged. But the only 
difference between class IIa and IIb, the limb salvage with disability was higher, i.e., 
62.5% compared to that of class IIa(12.5%). 
Limb salvagility is considered when the patient is completely ambulant normal and or 
with minor neurological deficit or underwent minor amputation. 
Other patients of class III ischemia(n=9), had undergone either a primary or secondary 
major amputation and six patients were died. Secondary amputations were required in 
patients where limb salvage was attempted and failed and also in one patient following 
primary below knee amputation who needed above knee for the ischemic stump.  
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All patients who underwent major amputation both primary or secondary were in class 
III ischemia. This difference was statistically significant(p<0.001). Precisely, the rate of 
limb salvage, limb salvage with diability, major amputation was 39%, 19.5% and 22%, 
respectively. Those who died were considered as limb salvage failures. 
 
The Mortality comparison with the outcome 
 
Mortality Outcome 
 Limb salvaged Major 
amputation 
Expired Total 
Yes 0 0 8 8 
No 24 9 0 33 
Total 24 9 8 41 
 
P < 0.01, significant 
In our study, when the outcome of patients were compared with the mortality, we found 
that none died following amputation including the secondary amputation following the 
surgical attemption for limb salvage. This difference was statistically significant(p < 
0.001). The causes of mortality were more due to associated cardiac illness in three 
patients and due to sepsis and rhabdomyolysis in each, of two patients. 
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The Mortality comparison with the Rutherford’s class of ischemia 
 
Class Mortality 
 Yes No 
I 0 7 
IIa 0 4 
IIb 0 11 
III 6 10 
Both 2 1 
Total 8 33 
Percentage 19.5 80.5 
 
P = 0.01189, significant  
 
In our study, the overall mortality rate was 19.5%, i.e., 8 patients out of 41 patients were 
expired(75% were in class III  and 25% were both lower limb different level ischemias). 
We found that 37.5% of patients with class III ischemia and 66.7% of both lower limb 
ischemia with different level occlusion were expired.  
 
The overall mortality rate of bilateral lower limb ischemia was 40% and that of the saddle 
aortoiliac occlusion was 42%. Out of this, saddle embolism and thrombosis had 60% and 
0% mortality rate, respectively. 
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DISCUSSION 
 This study, a two year prospective study conducted at Department of Vascular surgery, 
 Madras Medical College, Chennai, demonstrates that embolism is still one of the most 
common causes of acute lower limb ischemia and also the serious vascular emergencies.  
 
In our study, the iliac artery occlusion is the most frequent site of occlusion as compared 
to that of femoral artery bifurcation in many studies39,40,24. And femoral artery stands as 
the second most frequent site of occlusion and aortoiliac constitutes around 18% which is 
comparable to other studies. 
 
The overall mortality rate in our study was 19.5%. Mills and Porter41 found that the 
overall mortality was 12.5% in their series but higher rates ranging from 25 to 48% were 
noted in earlier reports42,43,44. Patients are in the middle age and the mean age was 40 
years. 75% of the mortality were in males. The operative outcome depends on many risk 
factors. 
 
In 1984, a study done by Richard et al45 at Massachussets General Hospital and Harvard 
Medical School, Boston, the mortality was higher in patients with embolic 
occlusion(20%)  and it was 8% in thrombosis. Even in our study, the embolic group had 
higher mortality (20.6%) when compared to the thrombotic group(16.6%). On the 
contrary, their rate of limb salvage was superior in patients with thrombosis compared to 
our study where both the groups had nearly equal rates. 
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The presumed origins of cardiac emboli were evident in 48% and rest of 52% could not 
be accurately determined. In a France study done by Jean- Pierre Becquemin and 
Stephane Kovarsky46 from the data collected from 24 centres showed that 33% did not 
show the origin of embolism. Also, they found that in 6% of patients echocardiography 
revealed the presence of intracardiac thrombus in patients with heart disease compared to 
that of 42% in our study revealed intracardiac thrombus. 
 
Several studies have shown that older patients have a higher mortality than younger and 
the mortality is higher in the proximal occlusions compared with distal occlusions47,48,49. 
But in our study, the mean age of patients died was 37 years and 62.5% of patients had 
above iliac level occlusion. The higher the mortality could be because of associated 
rheumatic heart disease in 50%(four) of our patients and 75% were males.  
 
Even in the past reports have shown that patients presenting with acute peripheral arterial 
occlusion were often in the 5th decade of life50,51,52. This represented the era of rheumatic 
heart disease associated with mitral valve deformity and resultant distal embolization 
were the most common causes of ischemia. 
 
Susequent data demonstrated that the mean age of patients with acute peripheral arterial 
occlusion was 70 years, reflected a shift in etiology from rheumatic to atherosclerotic 
heart disease and the increased frequency of peripheral atherosclerosis as an inciting 
cause for occlusion. 
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Surprisingly, in our study also it is going back to the past. Majority of our patients were 
in 4th decade and represented the rheumatic heart disease as the most common cause of 
acute ischemia. Atherosclerotic heart disease and peripheral atherosclerosis the second 
cause of our study both in embolism and thrombosis. 
 
In Dregelid et al53 patients with severe ischemia secondary to a proximal iliac occlusion 
had worst prognosis, with a 20% mortality and 40% amputation rate.  
Conversely, in our study iliac artery level occlusions were having better survival rate, 
limb salvage as well as higher amputation rates, 92.8%, 41.7%, 33.3%, respectively. 
 
A short duration of symptoms prior to embolectomy has been reported to increase 
mortality54,55 while others have found no effect on mortality49,50,51,56. In our study, also all 
of those patients died were presented less than a week duration prior to surgery. Probable 
explanation would be those patients delayed in presentation would have had  
time to improve the general condition and taken time for the development collateral 
circulation prior to surgery. And also patients who had class III ischemia arrived to early 
for the treatment and for whom delay in procedure could not be done for the fear of limb 
loss. Hence, there was no time for stabilizing these patients before surgery was 
undertaken. 
In our study the overall amputation was 22% as comparable to that of studies by 
Ljungman and Mills et al were amputation rates were ranged from 20 to 40%41,42 
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Like Kendrick et al57, McPhail et al 58 and Elliot et al59, our findings also indicate that the 
duration ischemia before treatment was a risk factor for death.  
 
According to Levy et al43, severe ischemia did not increase the mortality whereas, Balas 
et al60 reached the opposite conclusion. In our study, 75% were in class III and rest of 
25% were having bilateral limb involvement.  According to Richard et al, it is the 
preexisting disease largely determines prognosis regardless of the severity of 
ischemia61,62 and contradicts the notion that most of the deaths are caused by 
revascularization of the ischemic limb23. 
 
It is acknowledged that the severity of ischemia may be equally important as the amount 
of ischemic tissue concerning limb survival53. 
 
In our study of bilateral lower limb presentation, 75% had aortoiliac occlusion, out of this 
the mortality rate was 42%. This is nearly comparable with a retrospective study of acute 
aortic occlusion by Sateesh et al63 where the mortality rate was 52%. 
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CONCLUSION 
 
 
• Embolism is still the commonest causes of acute lower limb ischemia and cardiac 
is the commonest source.  
 
• Rheumatic heart disease is still more prevalent in our population even though 
there is a changing trend in the disease pattern towards atherosclerotic heart 
disease and peripheral atherosclerosis.  
 
• Even though it appears that the incidence of rheumatic heart disease is seemingly 
decreasing, the need of penicillin prophylaxis for rheumatic fever should be 
encouraged in the lower socioeconomic groups. The increased incidence of 
embolism could be due to non compliance of oral anticoagulation therapy and 
inadequate anticoagulation due to lack of monitoring. 
 
• Class III ischemia is the commonest presentation, probably because of lack of 
awareness in the public and availability of expertise. 
 
• Though the patients presented within a week of the onset of symptoms, the 
mortality in these patients were high. This could be due to various reasons, in 
limbs with class III ischemia as a consequence of which there will be metabolic 
derangements and also the need for urgent intervention without improving the 
general condition. So, this could be minimized by improving the general 
condition in those categories of patients where delay would not worsen the 
ischemia.  
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• Class III ischemia defined by Rutherford’s classification is based on paralysis 
with absence of venous signal by hand held Doppler. But however, the patients 
fulfilling the above criteria extends from the total insensate limbs and skin 
changes. Should we give a chance for revascularising in those patients with 
sensorymotor deficit without skin changes. In limbs with paralysis with absence 
of venous signal which are seemingly salvageable, the decision should be made in 
the operation theatre. 
 
• A small group of patients those from class IIB to III, the decision of primary 
amputation should be considered in operation theatre. Consent should be obtained 
for limb salvage procedure as well as amputation. The feasibility of 
revascularization should be assessed by an on table angiogram. If we salvage the 
limbs with myonecrosis, they will end up with permanent functional loss. The 
long term follow up of these patients are necessary before usefulness of 
attempting revascularization. 
 
• The severity of ischemia carries a very high risk of mortality and limb loss even 
with aggressive revascularization. Hence, class III ischemia should be advised 
primary amputation as a life saving measure(since all class III ischemia patients 
who underwent primary amputation survived). 
 
• All patients present with class IIa /IIb ischemias should be operated whenever 
feasible as the limb salvage rate is very good. 
 
• Patients with bilateral ischemia, though with class IIa/IIb have significant 
mortality. This may be due to the extent of tissue damage contributing to 
increased ischemic metabolites. The mortality may be reduced by intensive 
perioperative monitoring, postoperative ventilatory support and correction of 
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acidosis. Sequential declamping and intermittent reperfusing the limbs are 
mandatory. 
 
• Other modalities of treatment like thrombolytics and or anticoagulation alone 
should be considered for non limb threatening ischemia. 
 
 
• The benefit of limb salvage surgery must be weighed against the risk of increased 
mortality and the choice of treatment should be based on the influence of relevant 
factors on survival rates and amputation. 
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PROFORMA 
 
 
Serial No: 
Name:     Age/Sex: 
IP NO:     Address: 
DOA:    DOS:   DOD:   DOEx: 
 
Clinical presentation 
 
H/o Intermittent Claudication – Yes/No 
H/o rest pain/bluish or blackish discoloration/numbness/weakness 
H/o CVA/TIA/chest pain/palpitation/abdominal angina/urinary 
complaints/prev surgery or interventions 
 
Onset -   AM 
   PM 
 
Duration -   Hours/  days 
 
• Pain  
• Pallor    AK/BK/BA   
• Paresthesia   AK/BK/BA   
• Paralysis   Motor deficit – partial/total 
• Poikilothermia AK/BK/BA      
• Pulseless        RT       LT 
 
Fem   0/1/2/3   0/1/2/3 
Pop   0/1/2/3   0/1/2/3 
   AT/DP  0/1/2/3   0/1/2/3 
PT   0/1/2/3   0/1/2/3 
 
0-Absent, 1-Feeble, 2-Normal, 3-Bounding 
 
 
Bilateral Upper limb pulses 
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                RT               LT 
 
Fem  TP/BP/MP/Thump  TP/BP/MP/Thump  
Pop   TP/BP/MP/Thump  TP/BP/MP/Thump  
DP     TP/BP/MP/Thump  TP/BP/MP/Thump   
PT      TP/BP/MP/Thump  TP/BP/MP/Thump  
 PT Venous  Yes/No        Yes/No  
ABI    
 
Anatomical level   Unilateral – Right / Left 
Aortoiliac/ iliac/ femoral/ popliteal/ tibial/ pedal 
 
Rutherford Class – I / IIa /IIb / III 
 
 
Etiology – embolic/ thrombosis 
Embolic source - Cardiac / Aneurysm / proximal artery/ unknown 
Thrombosis – TAO / ASO / Vasculitis / Hypercoagulable/ Iatrogenic 
 
Risk Factors 
DM/HTN/CAD/RHD 
Details -  
Smoking – Beedies/Cigarette - years 
 
Investigations 
Hb -   PCV-   Platelets-      TC-       DC-  
RBS- 
Urea- 
Creat-   ESR -          CRP -  
 
ECHO 
LV Diastolic/Systolic dysfunction 
LVEF –  
Clot – Yes/No 
 
 
Angiography –Conventional/DSA/64 slice CT/MRA 
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Treatment – Heparin alone / Thrombolysis / Surgery 
 
Surgery  - Thrombectomy - Emg/Semielective 
  Embolectomy - Emg/Semielective 
  Bypass – Autologous/Synthetic 
  Primary amputation 
 
Outcomes 
RT   LT 
ABI      
 
Limb salvage – Ambulation/Minor Amputation  
 
Secondary Major amputation - BKA/AKA/Knee/Hip disarticulation 
 
Mortality 
 
Morbidity – Stump ischemia or infection/delayed wound healing/                                             
footdrop/RF/MI/Stroke/Respiratory/ 
 
 
 
 
 
 
 
 
 
MASTER CHART
Serial No. AGE Sex Days No. p  Class SIDE Level of Occlusion Pre op ABI Risk factors Smoking ETIOLOGY
1 45 M 4 days 4ps III Right Popliteal no flow smoking Embolic
2 70 M 15 days 2ps I Left Fempop no flow CAD smoking Embolic, Asc AAA 
3 41 M 25 days 2ps I  Right Fempop no flow HTN old CVA nil ASO, Thrombosis
4 55 M one day 4ps IIB Left Iliac no flow smoking Embolic
5 25 M 3 days 5ps III Right Fempop no flow RHD, MS, AF, CCF Embolic
6 45 M 2 days 2ps I Bilateral Aortoiliac 0.4, 0.27 HTN old CVA smoking ASO, Thrombosis
7 35 M 4 days 5ps III Right Popliteal no flow smoking Embolic
8 35 M one day 5ps III Left iliac no flow smoking Embolic
9 35 M 7 days 2ps IIA Right Popliteal no flow smoking TAO Thrombosis
10 37 M 15 days 5ps III Bilateral Aortoiliac no flow smoking ASO, Thrombosis
11 42 M 5 days 5ps III Left Popliteal no flow DM, HTN, CAD smoking ASO, Thrombosis
12 35 M 4 days 5ps III Left Iliac no flow smoking Hypercoagulable
13 48 M one day 3ps Rt III, Left IIA Bilateral Lt iliac rt fempop no flow RHD severe MS smoking Embolic
14 37 M 4 days 4ps III Right Iliac no flow smoking TAO Thrombosis
15 38 M 7 days 5ps IIB Right Iliac no flow smoking Embolic
16 38 M 20 days 3ps I Left Fempop no flow smoking Embolic
17 52 M 7 days 4ps IIB Left Popliteal 0.2 DM, HTN, CAD smoking Embolic
18 38 M 8 days 3ps I  Right Iliac no flow CAD smoking Embolic
19 45 Female 15 days 2ps I Left Iliac 0.6 RHD severe MS Embolic
20 65 M 7 days 3ps IIA Right Popliteal no flow smoking ASO, Thrombosis
21 35 M 10 days 5ps III Bilateral Aortoiliac no flow smoking Embolic
22 52 M 12 hours 4ps IIB Left Iliac no flow RHD, MS, CMV done smoking Embolic
23 35 M 8 days 4ps IIB Right Fempop venous smoking ASO, Thrombosis
24 45 M 7 days 5ps III Right Fempop no flow RHD severe MS smoking Embolic
25 27 M 4 days 5ps III Right Fempop no flow smoking Embolic
26 45 M 2days 4ps Rt IIB, Left IIA Bilateral Aortoiliac no flow smoking Embolic
27 55 M 2 days 4ps Rt IIB Lt IIA Bilateral Rt iliac and Lt fempop no flow Diarrhoea smoking ASO, Thrombosis
28 28 Female 4 days 4ps III Bilateral Aortoiliac no flow RHD severe MS Embolic
29 35 Female 5 days 4ps III Bilateral Aortoiliac no flow RHD severe MS Embolic
30 39 M 5 days 3ps IIA Right Popliteal no flow smoking ASO, Thrombosis
31 49 M 10 days 4ps IIB Right Iliac no flow smoking Embolic
32 55 M 14 days 3ps IIA Left Iliac 0.2 smoking ASO, Thrombosis
33 23 Female 2 days 5ps IIB Bilateral Rt fempop Lt iliac no flow  severe MS, CVA, lt hemiplegia Embolic
34 52 M 4 days 4ps IIB Left Popliteal no flow DM, HTN, CAD smoking Embolic
35 40 Female one day 5ps IIB Right Iliac no flow RHD, CVA Embolic
36 60 M one day 4ps IIB Right Popliteal no flow DM, HTN, CAD Embolic
37 30 M 20 days 2ps  I  Right Iliac no flow smoking Embolic
38 35 Female 4 days 5ps IIB Bilateral Aortoiliac no flow RHD severe MS Embolic
39 50 Female 10 days 5ps III Right Fempop no flow Embolic
40 40 M 3 days 5ps III Left Iliac no flow smoking Embolic
41 45 M 4 days 5ps III Left Iliac no flow smoking Embolic
